References

1.    United Nations General Assembly. United Nations Millennium Declaration. Geneva: UN, 2000. http://www.gtz.de/de/dokumente/en-0005-united-nation-millenium-declaration-eng.pdf [Accessed 16 April 2007].

2.    Department for International Development. Increasing access to essential medicines in the developing world: UK. Government policy and plans. London: DFID, 2004. http://www.dfid.gov.uk/pubs/files/accessmedicines.pdf [Accessed 16 April 2007].

3.    Commission on Intellectual Property Rights. Integrating Intellectual Property Rights and Development Policy. London: 2002. http://www.iprcommission.org/graphic/documents/final_report.htm [Accessed 16 April 2007].

4.    UK Intellectual Property Office. What is a patent? Newport: Patent Office, 2006. http://www.ipo.gov.uk/about/about-ourorg/about-contact.htm [Accessed 16 April 2007].

5.      Weissman, R. AIDS and Developing countries: Democratizing access to essential medicines. Foreign Policy in Focus 1999, 4(23), p.1-4.

6.      Oxfam International. Patents versus Patients: Five years after the Doha Declaration. Oxford: Oxfam International, 2006. http://www.oxfam.org.uk/what_we_do/issues/health/bp95_patents.htm [Accessed 16 April 2007].

7.      Scheffler, R.M., Pathania, V. Medicines and vaccines for the world’s poorest: Is there any prospect for public-private cooperation? Globalization and Health 2005, 1:10.

8.      United Nations. Report of the Special Rapporteur on the right of everyone to the enjoyment of the highest attainable standard of physical and mental health. Geneva: Office of the United Nations High Commissioner for Human Rights, 2006.

9.      Justo, L. A patent to kill? Comments on Resnik. Developing World Bioethics, 2(1), p.82-87.

10.      Medact. World Trade Organisation: Implications for Health Policy. London: Medact, 2000. http://www.medact.org/content/health/documents/wto/Health%20Counts%20and%20EPHA.pdf [Accessed 16 April 2007]

11.      World Trade Organisation. Understanding the WTO – members. Geneva: WTO, 2007. http://www.wto.org/english/thewto_e/whatis_e/tif_e/org6_e.htm [Accessed 16 April 2007]

12.      World Health Organization. Globalization, TRIPS and access to pharmaceuticals. Geneva: WHO, 2001. http://www.who.int/hiv/amds/regulations1.pdf [Accessed 16 April 2007]

13.      World Health Organisation Regional Office for the Western Pacific. TRIPS, Intellectual Property Rights and Access to Medicines. HIV/AIDS Antiretroviral Newsletter 2002, 8, p.1-5

14.      World Trade Organization. Implementation of paragraph 6 of the Doha Declaration on the TRIPS Agreement and public health. Geneva: WTO, 2003. http://www.wto.org/english/tratop_e/trips_e/implem_para6_e.htm [Accessed 16 April 2007]

15.      Brazil, what went right? The global challenge of access to treatment and the issue of compulsory licensing. TheBody.com,

December 2000. http://www.thebody.com/content/art1723.html [Accessed 16 April 2007]

16.      MSF Access Website. People before patents: the lives of millions are at stake. Campaign for Access to Essential Medicines, December 2006.

17.     http://www.accessmed-msf.org/prod/publications.asp?scntid=201220061154472&contenttype=PARA& [Accessed 16 April 2007]

18.      MSF Access Website. Former Swiss President joins call for Novartis to drop its case in India. Campaign for Access to Essential Medicines, February 2007. http://www.accessmed-msf.org/prod/publications.asp?scntid=1522007128462&contenttype=PARA& [Accessed 16 April 2007]

19.      MSF Access Website. MSF: Abbott should reconsider its unacceptable decision not to sell new medicines in Thailand. Campaign for Access to Essential Medicines, March 2007. http://www.accessmed-msf.org/prod/publications.asp?scntid=2332007121275&contenttype=PARA& [Accessed 16 April 2007]